| Yang, Tae-Hyun |
| Recruiting | 4 | 492 | RoW | Prasugrel 5mg, Effient, Ticagrelor 60mg, Brillinta | Gyeongsang National University Hospital, U&I Corporation | Coronary Artery Disease | 06/21 | 06/22 | | |
PROTECT-HBR, NCT04416581: Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy |
|
|
| Recruiting | 4 | 3100 | RoW | PPI, P-CAB 50 | Duk-Woo Park, MD | Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndrome, Myocardial Infarction | 09/26 | 12/27 | | |
| Recruiting | N/A | 4500 | RoW | Onyx Drug Eluting Stent group | Seung-Jung Park, CardioVascular Research Foundation, Korea, Medtronic Korea Co., Ltd. | Coronary Artery Disease, Arterial Occlusive Diseases, Cardiovascular Diseases, Percutaneous Transluminal Angioplasty | 12/25 | 12/29 | | |
NCT02792075: Prognosis of Coronary Stenosis Based on Intracoronary Imaging; A Multicenter, Prospective Observational Study |
|
|
| Recruiting | N/A | 4000 | RoW | 5-year Follow-up | Seung-Jung Park, CardioVascular Research Foundation, Korea | Coronary Artery Disease | 01/25 | 06/29 | | |
NCT05807841: Clinical Impact of Intravascular Ultrasound-Based Artificial Intelligence Technologies (INNOVATE-PCI) |
|
|
| Recruiting | N/A | 3000 | RoW | percutaneous coronary intervention | Asan Medical Center, Boston Scientific Corporation | Coronary Artery Disease | 06/28 | 06/29 | | |
ASSIST, NCT05529459: Anatomic Versus Physiologic Guidance for Complete Revascularization With DES Eluting in Patients With CAD |
|
|
| Recruiting | N/A | 2400 | RoW | Percutaneous Coronary Intervention | Seung-Whan Lee, M.D., Ph.D., Biotronik Korea Co., Ltd | Coronary Disease | 12/26 | 07/30 | | |
| Recruiting | N/A | 10000 | RoW | | Seung-Jung Park, CardioVascular Research Foundation, Korea | Coronary Artery Disease | 12/32 | 12/33 | | |
| Kim, Hee-Yeol |
| Active, not recruiting | N/A | 994 | RoW | Staged in-hospital or Immediate complete revascularization | Chonnam National University Hospital | Myocardial Infarction, Acute, Multi-Vessel Coronary Artery Stenosis | 02/25 | 12/29 | | |
| Kim, Yong-Hyun |
BEconneCTD-ILD, NCT06572384: A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease |
|
|
| Recruiting | 3 | 440 | Europe, Japan, US, RoW | Belimumab, BENLYSTA, GSK1550188, Placebo | GlaxoSmithKline | Lung Diseases, Interstitial | 10/28 | 12/28 | | |
| Eunchul, Kim |
NCT05733624: Clinical Trial to Evaluate the Safety and Efficacy of SCAI-001 Compared to Restasis |
|
|
| Completed | 2 | 116 | RoW | SCAI-001 0.01% eyedrop, Cyclosporine 0.01%, SCAI-001 0.02% eyedrop, Cyclosporine 0.02%, Restasis 0.05% eyedrop, Cyclosporine 0.05% | SCAI Therapeutics | Dry Eye Syndromes | 08/23 | 02/24 | | |
